The guide

When ApoB and LDL disagree

By GyroscopeUpdated November 15, 20266 sources

Most of the time your ApoB and LDL tell the same story. They split most often with high triglycerides, diabetes, extra weight or a statin, and when they do, the 2026 US guideline says ApoB is the better guide. Put your two numbers in the four corners below to see where you land.

Why a normal LDL feels like the all-clear

LDL has been the cholesterol number for decades, and for most people it tracks ApoB closely. In UK Biobank the two lined up at a correlation of 0.96. If your LDL is under its goal, it’s natural to assume the rest is fine too.

The trouble is who the exceptions are. The guideline says the split “is most common in individuals with cardiometabolic disease, including ASCVD, CKM syndrome, diabetes, and/or TG ≥150 mg/dL”. That means heart disease, kidney and metabolic disease, diabetes, and triglycerides of 150 or more. Those are the people who most need an accurate number.

The four corners

Each number gets compared with its own goal, from the same row of the National Lipid Association’s table. At borderline or intermediate risk that’s LDL under 100 and ApoB under 90. At high risk it’s 70 and 70, and after a heart attack or stroke 55 and 60.

Take a 45 year old man with an ApoB of 112 and an LDL of 95 who doesn’t know his risk band. His LDL is under 100 and at about the 30th percentile of untreated American adults. His ApoB is at about the 79th, 22 points over 90. That’s a hidden count.

Who lands where

A hidden count usually comes from particles that carry less cholesterol than normal. The NLA says high triglycerides, extra weight and insulin resistance “can lead to smaller cholesterol-depleted LDL particles and result in lower LDL-C but still elevated apoB levels”. Statins can do it too. They tend to clear the larger, more cholesterol-rich LDL particles first, so LDL falls further than ApoB (ApoB on a statin).

A cholesterol-rich pair is the reverse, fewer particles that each carry more. In the Copenhagen study of 13,015 statin users, a high LDL with a low ApoB wasn’t linked to more heart attacks or deaths over about 8 years. Those were people already on a statin, so it isn’t permission to ignore a high LDL. An LDL of 190 or more is a doctor visit whatever your ApoB says, and cholesterol.guide explains why.

Like a few big trucks or a lot of small vans

Moving a ton of cargo takes either a few big trucks or a lot of small vans. Weigh the cargo and the two look the same. Count the vehicles and the vans fill the road. LDL weighs the cargo, and ApoB counts the vehicles. A hidden count is the road full of vans.

One LDL, a spread of counts

A 2024 study of 293,876 UK Biobank adults aged 40 to 73 showed how wide the spread gets. Among people with an LDL of about 130, 95% had an ApoB somewhere between 86 and 109. Those with an ApoB at least one standard step above average had nearly twice the rate of new heart disease and strokes over 10 years as those at least one step below (7.3 against 4.0 in the paper), at the same LDL.

Triglycerides were worse still as a stand-in. At triglycerides of 115, ApoB ran from 68 to 147. The authors concluded that LDL, non-HDL and triglycerides “are not adequate proxies for apoB in clinical care”.

How much of it is the formula

On many reports nobody measured the LDL. The lab worked it out from your total cholesterol, HDL and triglycerides, often with an old formula called Friedewald. The guideline says that formula gets less accurate as triglycerides rise and LDL falls, which is where the disagreement shows up most.

The 2026 guideline says the newer Martin/Hopkins method “markedly reduces discordance with apoB compared with the Friedewald equation”. With it, only about 2% of people with an LDL under 70, and about 1% under 100, had an ApoB and non-HDL over the goals. The guideline now prefers Martin/Hopkins or a third method, Sampson/NIH, to Friedewald. If your report says “calculated”, the tool below can work your LDL out again with Sampson/NIH from your total, HDL and triglycerides.

It starts young

In CARDIA, 2,794 Americans had ApoB and LDL measured at 18 to 30 and a scan of their heart arteries 25 years later. Those whose ApoB was high while their LDL was low had 1.55 times the odds of calcium in their arteries by midlife, after allowing for the usual risk factors. A hidden count in your twenties still counts.

What we don’t know

The corner studies follow people and see what happens to them. Nobody has taken people with a hidden count and randomly treated half of them to bring the ApoB down. The case that the ApoB is the one to act on rests on the gene studies, where the count predicted heart disease whichever fat the genes lowered (why heart attacks follow the count). We find that convincing enough to plan around the ApoB.